Vase.Ns

VASE.NS exhibits a strong capital structure with a current ratio of 7.57, indicating a robust short-term liquidity position. The company's total equity of INR 1,325,152,000 and minimal long-term debt of INR 1,180,000 suggest a conservative approach to capital management. However, the company's operating cash flow of -INR 35,517,000 and free cash flow of -INR 22,093,000 indicate a need for careful monitoring of cash flow generation.

Profitability metrics show that VASE.NS has a return on equity of 12.8% and a return on assets of 11.22%, which are strong indicators of efficient use of equity and assets. The company's operating income of INR 214,443,000 and net income of INR 169,676,000 reflect a healthy bottom-line performance. These figures are in line with the industry's preferred metrics, suggesting that VASE.NS is performing well relative to its peers.

The company's revenue is concentrated in a single segment, which is the health care providers and services domain. This concentration may pose a risk if the segment faces any downturn. Geographically, the company's exposure is not disclosed, but the lack of diversification in segments could impact its resilience to market fluctuations.

Looking at the growth trajectory, VASE.NS has shown a consistent revenue performance with a total revenue of INR 2,493,657,000. The company's capital expenditure of -INR 208,360,000 indicates a significant investment in infrastructure, which could support future growth. However, the negative operating and free cash flows suggest that the company may need to manage its expenses more effectively to sustain growth.

Risk factors for VASE.NS include a medium liquidity risk due to negative net cash after subtracting total debt. The company's dilution potential is low, and no significant adjustments have been applied to its valuations. These factors suggest that while the company is not currently facing high dilution risks, it should remain cautious about its liquidity position.

Recent events and filings do not indicate any major changes in the company's operations or financial strategy. The company's financial health appears stable, but it should continue to monitor its cash flow and capital expenditures to ensure long-term sustainability.